Cyberdyne Inc. · TSE:7779

Cyberdyne — FY2023 Earnings Presentation

51 slides from Cyberdyne's earnings presentation, May 15, 2024

  1. Slide 1: FY March 2024 Financial Results Supplementary Materials

    2024 3 CYBERDYNE 2024 5 15

  2. Slide 2: CYBERDYNE

    CYBERDYNE

  3. Slide 3: EBITDA

    EBITDA = ±

  4. Slide 4: Slide 4

  5. Slide 5: ) _—

    ) _—

  6. Slide 6: Financial results

    \y Jor eerarne

  7. Slide 7: Slide 7

  8. Slide 8: Changes in results by item

    7 +34 +36 +27 +7 19 +38 14 +28 +3 +160 6 +38 +236 +27 +32

  9. Slide 9: CYBERDYNE

    CYBERDYNE

  10. Slide 10: Society 5.0/5.1

    Society Society Society Society Society 5.0/5.1 1.0 2.0 3.0 4.0

  11. Slide 11: AI and Cybernics technology

    Ditty k * Al Cybernics " FINDA) Al Al Ditty b ER IRR? Al FIRST ImPACT SIP

  12. Slide 12: Product lineup

    wees BoRERS BI AIT ! a ere Ag + MN + 74 DAIS Fla wrod aon HCPSHAT7/OY— ore Dik y hE ITER 't4N6oDAEX, Fi: PER - RRERTT Cleaning Robot HAL Lumbar Type fo! ‘Autonomous robe i Well-being @R product that supports both caregivers and care~ HAL Lumbar Type for Well-being A product that RRS MESORLE aregive

  13. Slide 13: CYBERDYNE

    CYBERDYNE

  14. Slide 14: Medical HAL

    Medical HAL hybrid assistive limb Technology is worth nothing it S used in real life

  15. Slide 15: ■ “ 3.5 CK ※※ ”

    ■ “ 5 3.5 CK ※※ ”

  16. Slide 16: Slide 16

  17. Slide 17: International Conference on Cybernics HAL 2023

    INTERNATIONAL CONFERENCE on CYBERNICS HAL 2023

  18. Slide 18: Cybernics & Neurobionics Summit 2024

    Cybernics & Neurobionics Summit 2024 INI* * International Neuroscience Institute Dr. Madjid Samii ( ) - INI President Dr. Amir Samii ( ) - INI Vice President

  19. Slide 19: FDA HAL

    FDA HAL * (2024/5/7) ©

  20. Slide 20: HTLV-1 HAM

    2023/10 HTLV-1 HAM 2024/5 !! HTLV-1

  21. Slide 21: Overseas business

    Qereerarwe 900

  22. Slide 22: EU, EMEA, APAC expansion

    HTLV-1 HAM HTLV-1 HAM EU EMEA APAC

  23. Slide 23: EMEA APAC

    20 g | oO < < | wi = wi PF

  24. Slide 24: RISE

    RISE ✦ LA ✦ 2023 ✦ *2.4 ✦ Top3 ✦ / / 76%

  25. Slide 25: Cyberdyne Malaysia

    CYBERDYNE MALAYSIA HAL SDN. BHD. HAL PERKESO APAC

  26. Slide 26: Socso urged to build three new rehabilitation centres

    HAL 12 Socso urged to build three new rehabilitation centres in five years Bernama ov, Ores ie

  27. Slide 27: Slide 27

  28. Slide 28: G-BA

    G-BA 2023/01 2023/03 2023/09 → 2024 3 CRO G-BA (Federal Joint Committee, ) §137e SGB V Trial Regulation: : G-BA CRO: (Contract Research Organization)

  29. Slide 29: Coopselios / Italian Cybernic Center

    Coopselios 25 HAL 1,000 ✦ Italian Cybernic Center - Second walk ✓ 1984 ✦ ✓ ✦ Coopselios ✓ 8 6,500 ✓ 3,000

  30. Slide 30: CYBERDYNE

    CYBERDYNE

  31. Slide 31: Neuro HALFIT

    Neuro HALFIT

  32. Slide 32: Neuro HALFIT

    Neuro HALFIT

  33. Slide 33: Neuro HALFIT

    Neuro HALFIT Amores | eA = ARORST PHVA SULEORT Pea {eORKSP eV a KR MEREOEED SReilan sete” | oy | DOKI T EY 9— ARE FUR < eT MuOKSP eye | . \ 4 REP EY ARIE Bue ‘ \ é SBE ——, » - —————————— RBORTP ey a *\ MRARTT ty a Tae UE RAs $, ve: FRET ~ BvYSoRTT eva— RT CaE ShRORSP eye EE MMORT? ey a— SHRed eH me

  34. Slide 34: HAL clinical results

    HAL HAL HAL Mean Mean P (95%CI) (95%CI) 10m ( m/sec) 1.05 1.43 36% <0.001*** 0.98, 1.12) 1.35, 1.51) 8.5 4.4 93% <0.001*** ※ (7.7, 9.3) (3.3, 5.4) ®︎

  35. Slide 35: Neuro HALFIT

    Neuro HALFIT® HAL*S=4— (4 X—-Y)

  36. Slide 36: HAL

    HAL

  37. Slide 37: OS

    OS

  38. Slide 38: CYBERDYNE

    CYBERDYNE

  39. Slide 39: Slide 39

  40. Slide 40: SIP

    (SIP) 1) 2) ( ) HCPS ( ) 3) HCPS 4)

  41. Slide 41: Pre-Hospital, Hospital, Post-Hospital

    Pre-Hospital Hospital Post-Hospital

  42. Slide 42: ✅ ✅

    ✅ ✅

  43. Slide 43: Slide 43

  44. Slide 44: Innovative Cybernics System, Cloud Computing

    with innovative Cybernics System Cloud Computing

  45. Slide 45: LED biophotonics

    |) BIOPHOTONIGS SINGIN LICH Ta MEeE SCIENCES — > LEDS tieip to Pi Diseased Tissue

  46. Slide 46: Research collaborations

    Qereenorne toi - AZ Wemsterdomume | a UNIVERSITY OF TWENTE. | Pennstate| Stanford MEDICINE ‘University College (ZS London Hospitals (nstitut Langevin », | POLITECNICO DI TORINO i ( \ |) COYBGEROYNE 1 sEHak

  47. Slide 47: C-Startup

    C-Startup Kringle Pharma is J a . Rehab wt Ru GARA BioMEDICINE nom amui ; sm as ge Hirosaki oOo KanonCure ° Xenoma PLIMES e fo METCELA ANSeeN Q Lirescaprs Pitkey Mo eixve. SAvcuse he om al Cs Bee eettss OAillis @W®@ robotics RRB — ‘BEROYNE & & & Allngaes © crecrorne QO XMNTALRAASH N— @ ARID DADO XAE

  48. Slide 48: C-Startup

    C-Startup CYBERDYNE

  49. Slide 49: C-Startup

    Tamagawa Sky SRNIZDIT ame/ 42 A ae YODOBASHI CAMERA ~<“vAssembly Center SRA 7-Eleven

  50. Slide 50: CYBERDYNE

    Qoreerorve

  51. Slide 51: CYBERDYNE

    Qoreerorve

Cyberdyne — FY2023 Earnings Presentation on 6ix